MedPath

Platelet-Rich Plasma and Hip Osteoarthritis

Not Applicable
Completed
Conditions
Hip Osteoarthritis
Registration Number
NCT04820231
Lead Sponsor
Sisli Hamidiye Etfal Training and Research Hospital
Brief Summary

To evaluate the effect of platelet-rich plasma (PRP) injection on pain, function and quality of life in patients with hip osteoarthritis.

Detailed Description

After being informed about the study and potential risk, all patients giving written informed consent will undergo study entry.

Each patient received three times intra-articuler injections of PRP under ultrasound guidance, and they were administered once a week.

Baseline: Visual Analog Scale (VAS) including movement, rest and night, the Western Ontario and McMaster University Osteoarthritis Index (WOMAC) and SF-36 assessment

1st month: VAS, WOMAC and SF-36 assessment

3rd month: VAS, WOMAC and SF-36 assessment

6th month: VAS, WOMAC and SF-36 assessment

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Hip pain VAS > 4
  • Grade 1 and 2 osteoarthritis according to the Kellgren-Lawrence classification
  • No pathologies in the laboratory and coagulation parameters
Exclusion Criteria
  • Rheumatological disease with hip involvement
  • Systemic active infection
  • Severe cardiovascular disease
  • Malignancy
  • NSAID usage in the last week
  • History of hip joint surgery
  • History of traumatic hip injury
  • Hgb values < 11 gr/dl
  • Platelets values < 150.000 / µl
  • History of bleeding disorder

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Change from baseline Visual Analog Scale (VAS) score at 1-month, 3-month and 6-monthBaseline, 1st month, 3rd month, 6th month

The VAS is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 10-cm line that represents a continuum between 'no pain' and 'worst pain'.

Change from baseline SF-36 score at 1-month, 3-month and 6-monthBaseline, 1st month, 3rd month, 6th month

The SF-36 is a 36-item self-report measure of health-related quality of life. It has eight subscales measuring different domains of health-related quality of life: physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health . Two component scores are derived from the eight subscales: a physical health component score and a mental health component score.

High scores: good quality of life

Change from baseline Western Ontario and McMaster University Osteoarthritis Index (WOMAC) score at 1-month, 3-month and 6-monthBaseline, 1st month, 3rd month, 6th month

The scores for each subscale are summed up, with a possible score range of 0-20 for Pain, 0-8 for Stiffness, and 0-68 for Physical Function. Usually a sum of the scores for all three subscales gives a total WOMAC score, however there are other methods that have been used to combine scores.

Higher scores: worse pain, stiffness, and functional limitations.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Şişli Hamidiye Etfal Training and Research Hospital

🇹🇷

İstanbul, Şişli, Turkey

Şişli Hamidiye Etfal Training and Research Hospital
🇹🇷İstanbul, Şişli, Turkey

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.